IT|EN
DIABETOLOGY AND ITS COMPLICATIONS · METABOLIC SYNDROME AND OBESITY +1

MICROPOLI

Micro- and nanodevices delivering polyphenols isolated from olive-supply-chain by-products as novel dietary supplements.

The development of innovative nutraceuticals based on polyphenols extracted from olive-supply-chain by-products and delivered through high-bioavailability micro- and nanodevices.

CompletedStatus
48 monthsDuration
May 2021Start
Diabetology and its complications · Metabolic syndrome and obesity +1Areas

The project

The MICRO-POLI project is aimed at developing innovative nutraceuticals based on polyphenols extracted from by-products of the extra-virgin olive oil (EVOO) supply chain, through advanced micro- and nano-encapsulation technologies.
The initiative fits within the context of valorising agri-food waste with a high content of bioactive molecules, with the aim of transforming it into formulations with high health-promoting potential. The research activities involved the development of eco-sustainable extraction processes for the isolation of high-purity polyphenols from matrices such as vegetation water, pomace and EVOO filtration residues, reducing the use of organic solvents and the environmental impact.
The micro- and nanostructured systems developed make it possible to improve the stability, bioavailability, palatability and systemic absorption of the bioactive compounds, fostering applications in the prevention of chronic metabolic diseases and in cellular ageing processes. The project integrates nanotechnology, biotechnology and circular-economy principles into an advanced model of sustainable innovation.

Results

The objectives of the MICRO-POLI project concern the development and industrial validation of innovative micro- and nanodevices for the controlled release of polyphenols extracted from olive-supply-chain by-products.
The project activities include the design of high-efficiency, eco-sustainable extraction processes, the chemical and physical characterisation of the bioactive molecules and the optimisation of advanced delivery systems capable of increasing the bioavailability and stability of the nutraceutical compounds.
Further objectives include improving consumer compliance by optimising the palatability of the formulations and assessing tolerability, safety and the absence of toxicity through studies on subjects with chronic metabolic diseases The project also promotes the valorisation of agri-food waste in accordance with the principles of circular economy, green economy and environmental sustainability, fostering technology transfer towards the nutraceutical and biomedical sectors.
The MICRO-POLI project enabled the development and validation of innovative nutraceutical formulations based on polyphenols extracted from by-products of the extra-virgin olive oil (EVOO) supply chain, delivered through high-bioavailability micro- and nanodevices.
Eco-sustainable extraction methods were optimised for the isolation and purification of bioactive molecules, with a reduction in the use of organic solvents and an improvement in process efficiency.
In parallel, technological platforms were created for the controlled release of the active ingredients, aimed at improving the chemical stability and biological yield of the compounds.
The formulations developed showed an increase in systemic bioavailability and better palatability than conventional nutraceuticals, with favourable tolerability and safety profiles.
The project also contributed to the valorisation of agri-food waste, promoting development models based on circular economy and environmental sustainability, with potential repercussions in the nutraceutical, pharmaceutical and cosmeceutical sectors.

Related publications

Scientific evidence

2026
Diabetology and its complications

The Therapeutic Potential Of Incretin-Based Therapies And The Emerging Role Of Metabolic Modulation In The Management Of Obstructive Sleep Apnea: A Mechanistic And Clinical Review

Sandro Gentile, Ersilia Satta, Giuseppina Guarino, Carmine Romano, Felice Strollo

World Journal of Pharmaceutical Science and Research
2026
Diabetology and its complications

Pen Needle Reuse in People with Diabetes Who Inject Insulin: A Narrative Review

Diana Isaacs, Davida Kruger, Susan Cornell, Sanjay Kalra, Sandro Gentile

Diabetes Therapy
2026
Diabetology and its complications

Consensus Recommendations on Lipohypertrophy: Insights From an International Panel of Experts

Lixin Guo a, David C. Klonoff b, Saud N. Al Sifri c, Yong Mong Bee d, Luis Eduardo Calliari e, Liming Chen…

Diabetes Research and Clinical Practice
2026
Diabetology and its complications

Enhancing Insulin Therapy Adherence Through Technology: Which Needles Do People with Diabetes Prefer?

Sandro Gentile, Raffaella Fiorentino, Maddalena Lettieri, Giuseppina Guarino, Giampiero Marino, Elisabetta Tommasi, Vera Frison, Ersilia Satta, Maria Chiarello, Giuseppe Caccavale, Emilia Masuccio…

MDPI
2025
Diabetology and its complications Review

A Neglected Complication of Insulin Therapy Due to Errors in Injection Technique: Skin Lipohypertrophies: A Narrative Review

Guarino G, Satta E, Gentile S

2025
Diabetology and its complications Review

Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations

Kerr D, Klonoff DC, et al.